Cohort study2015

Prospective study of breast cancer in relation to coffee, tea and caffeine in Sweden

Oh JK, Sandin S, Ström P, Löf M, Adami HO, Weiderpass E

International journal of cancer · 49 citations

How it was studied

Design
Cohort study (indexed by PubMed)
Studied in
People
Main outcome
Clinical events such as disease or death

Who paid for it

Funding
Independent funding
Government
Vetenskapsrådet
Government
Swedish Research Council
Grants
Vetenskapsrådet (K2012–69X-22062–01-3)

Based on 2 listed funder(s).

Publication

Published
2015-04-17 · Int J Cancer · vol. 137 · issue 8 · pp. 1979–1989
Publisher
Wiley
Cited
71 citations · more than 96% of similar papers · 6.1× the field average
Impact
Top 10% most cited in its field
References
62 works
Access
Free to read
Research areas
Coffee research and impacts · Tea Polyphenols and Effects · Nutritional Studies and Diet
Keywords
Medicine, Caffeine, Breast cancer, Relative risk, Poisson regression, Confounding, Confidence interval, Prospective cohort study, Lower risk, Incidence (geometry), Cancer, Gynecology, Demography, Internal medicine, Environmental health, Population
MeSH
humans, breast neoplasms, caffeine, receptors, estrogen, receptors, progesterone, risk factors, regression analysis, follow-up studies, prospective studies, coffee, tea, adult, middle aged, sweden, female

6 authors

From SE, KR, US, NO, FI

  • Jin‐Kyoung OhKarolinska Institutet; National Cancer Center
  • Sven SandinKarolinska Institutet
  • Peter C. StrømKarolinska Institutet
  • Marie LöfKarolinska Institutet
  • Hans‐Olov AdamiHarvard University; Karolinska Institutet
  • Elisabete Weiderpass · correspondingKarolinska Institutet; Cancer Registry of Norway; Folkhälsans Forskningscentrum; UiT The Arctic University of Norway

Abstract

Studies of coffee and tea consumption and caffeine intake as risk factors for breast cancer are inconclusive. We assessed coffee and tea consumption, caffeine intake, and possible confounding factors among 42,099 women from the Swedish Women's Lifestyle and Health study, the participants of which were aged 30-49 years at enrollment in 1991-1992. Complete follow-up for breast cancer incidence was performed through 2012 via linkage to national registries. Poisson regression models were used to estimate relative risks (RRs) and 95% confidence intervals (CIs) for breast cancer. During follow-up 1,395 breast cancers were diagnosed. The RR was 0.97 (95% CI 0.94-0.99) for a 1-unit increase in cups of coffee/day, 1.14 (95% CI 1.05-1.24) for a 1-unit increase in cups of tea/day, and 0.97 (95% CI 0.95-1.00) for a 100 mg/day increase in caffeine intake. Although the RR for no consumption (RR = 0.86, 95% CI 0.69-1.08), a group with a relatively small number of women, was not statistically significant, women with higher consumption had a decreased breast cancer risk (3-4 cups/day: RR = 0.87, 95% CI 0.76-1.00; ≥5 cups/day: RR = 0.81, 95% CI 0.70-0.94) compared to women consuming 1-2 cups of coffee/day. Compared to no consumption, women consuming >1 cups tea/day showed an increased breast cancer risk (RR = 1.19, 95% CI 1.00-1.42). Similar patterns of estimates were observed for breast cancer risk overall, during pre- and postmenopausal years, and for ER+ or PR+ breast cancer, but not for ER- and PR- breast cancer. Our findings suggest that coffee consumption and caffeine intake is negatively associated with the risk of overall and ER+/PR- breast cancer, and tea consumption is positively associated with the risk of overall and ER+/PR+ breast cancer.

Abstract via Europe PMC. Copyright remains with the authors or publisher.

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.